COMMUNIQUÉS West-GlobeNewswire

Hemispherx Biopharma's CEO to Present at Planet MicroCap Showcase 2019
25/04/2019
OCALA, Fla., April 25, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc., an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, announced today that CEO [...]
Vericel to Report First-Quarter 2019 Financial Results on May 7, 2019
25/04/2019
CAMBRIDGE, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and [...]
Uptick Newswire Hosts ImmunoPrecise Antibodies Ltd. on the Stock Day Podcast to Discuss Their Rapid Growth in the Antibody Discovery Space
25/04/2019
PHOENIX, April 25, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed ImmunoPrecise Antibodies Ltd. (IPATF) (“the Company”), a full-service, therapeutic antibody discovery company focused on the next [...]
HOOKIPA Appoints David R. Kaufman to its Board of Directors
25/04/2019
NEW YORK and VIENNA, Austria, April 25, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its [...]
Leading BioSciences to Present at Planet MicroCap Showcase 2019
25/04/2019
CARLSBAD, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome ™ , today announced that its chief [...]
Philips introduces VitalMinds, new non-pharmacological approach to help reduce delirium in the ICU
25/04/2019
April 25, 2019 Key technology of the multi-component solution is the VitalSky personalized light therapy system, now with CE Mark as a medical device VitalSky improves sleep quality in intensive care patients to help [...]
The Joint Corp. to Host Conference Call on Thursday, May 9 to Discuss First Quarter 2019 Results
25/04/2019
SCOTTSDALE, Ariz., April 25, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will report its first quarter 2019 financial [...]
IntelGenx to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
25/04/2019
SAINT LAURENT, Quebec, April 25, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that its Executive Vice-President and Chief [...]
miRagen Therapeutics to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8th
25/04/2019
BOULDER, Colo., April 25, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]
Cyclerion to Host Corporate Overview Call on May 13, 2019
25/04/2019
CAMBRIDGE, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company focused on the development of soluble guanylate cyclase (sGC) stimulators for [...]
CMS’ New Value-Based Payment Program is a Catalyst for Tabula Rasa HealthCare
25/04/2019
Under new policy changes, more patients and providers will benefit from TRHC’s medication safety technology, resulting in improved quality of care and patient outcomes MOORESTOWN, N.J., April 25, 2019 (GLOBE NEWSWIRE [...]
Lexington Biosciences to Consolidate its Common Shares
25/04/2019
VANCOUVER, British Columbia, April 25, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces that effective at the opening of markets on April 26, 2019, [...]
North Bud Farms Simplifies Trading in the U.S. Market with DTC Eligibility
25/04/2019
TORONTO, April 25, 2019 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) ("NORTHBUD" or the "Company") is pleased to announce it has received approval from The Depository Trust Company (“DTC”) of New [...]
Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Thursday, May 2, 2019
25/04/2019
CAMBRIDGE, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing monoclonal microbials, a potential new modality of oral biologic [...]
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2019 Earnings and Company Update
25/04/2019
CAMBRIDGE, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and [...]
Verona Pharma to Host Investor & Analyst R&D Forum in London on May 8, 2019
25/04/2019
LONDON, April 25, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it [...]
Clearside Biomedical to Report First Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, May 8, 2019
25/04/2019
ALPHARETTA, Ga., April 25, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2019
25/04/2019
Press Release 25 April 2019 Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2019 At the Annual General Meeting (the "AGM") of Immunicum AB (publ), reg. no 556629-1786, (the "Company"), on [...]
Optinose to Report First Quarter 2019 Financial Results and Corporate Updates on May 9, 2019
25/04/2019
Conference Call and Webcast Scheduled for Thursday, May 9 at 8:00 a.m. Eastern Time YARDLEY, Pa., April 25, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, [...]

Pages